E-scooters reduce bike collision risk, says Bristol University study
Electric scooter schemes appear to reduce the risk of bicycle collisions by about 20%, according to a study.University of Bristol researchers compared bicycle collision rates in areas before and after the introduction of e-scooter schemes, with rates in areas without them.The study, published in the journal Injury Prevention on Friday, looked at routinely collected police data on road collisions in the UK between 2015 and 2023."If more people are encouraged to cycle, because the roads are safer, there are potentially even larger positive effects," said Yoav Ben-Shlomo, professor of clinical epidemiology at the University of Bristol.
Many rental e-scooter schemes were introduced after the Covid pandemic and police data showed that while overall traffic collisions returned to pre-pandemic levels, bicycle collisions were down by about 20% in areas with scooter schemes.Combining cycle and e-scooter collisions did not change the results – suggesting that the reduction in bicycle collisions was not masked by more e-scooter collisions, researchers said.They believe that the findings support the idea that more people using e-scooters and bicycles leads to greater overall safety as they and motorists become more alert to each other."We were delighted to confirm the safety in numbers hypothesis but we need further data to be sure this is a real effect," said Professor Ben-Shlomo.Zoe Banks Gross, founder of cycling group East Bristol Kidical Mass, said: "Increasing actual and perceived safety is important to encourage more people to cycle." Last year, police confirmed that e-scooters were linked to more than 100 road collisions in Bristol in a one-year period – accounting for about 10% of serious crashes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
16 hours ago
- Daily Mirror
Seven symptoms you need to look out for as doctors issue Covid warning
A new variant now spreading across Europe and multiple other continents could leave people with a host of unpleasant symptoms - that don't feel like classic Covid Health officials have warned that people could experience a host of nasty and unusual symptoms if they contract the latest Coronavirus strain. The new variant, named NB.1.8.1, was designated a "SARS-CoV-2 variant under monitoring (VUM)" on May 23, one of six emerging variants currently under WHO monitoring. As of this month, it has crossed multiple continents, with cases flagged in the UK and Ireland in Europe, and further afield in the US and Australia. People have been urged to stay at home for days on end if they find they have symptoms of the new Covid variant, which are a far cry from the classic flu-like signs of their predecessors. While early signs of Covid once included symptoms like a severe cough, sore throat and high fever, NB.1.8.1 is felt most acutely in the gastrointestinal tract. Symptoms of the variant include: Nausea Vomiting Diarrhoea Heartburn Bloating Constipation Abdominal pain Dr Lara Herrero, associate professor and virology research leader at Griffith University in Australia, explained in an article posted on The Conversation that the variant appears to be spreading faster than its predecessors. Of those, Dr Herrero said, it is most similar to subvariants of the Omicron lineage. She said: 'The evidence so far suggests NB.1.8.1 may spread more easily and may partially sidestep immunity from prior infections or vaccination. 'Reports suggest symptoms of NB.1.8.1 should align closely with other Omicron subvariants." The WHO has said the same, stating in its report that the variant has obtained a series of mutations that allow it both to spread easier and potentially evade antibody protections afforded to people by previous infections. The organisation explained: "Spike mutations at position 445 have been shown to enhance binding affinity to hACE2, which could increase the variant's transmissibility." It adds: "Mutations at position 435 shown to reduce the neutralisation potency of class 1 andclass 1/4 antibodies, and mutations at position 478 shown to enhance the evasion of Class 1/2 antibodies." People who exhibit any symptoms have been told to stay indoors by the UK Health Security Agency (UKHSA) which advises people to "avoid contact with vulnerable people and stay at home if possible" for 48 hours.
Scottish Sun
17 hours ago
- Scottish Sun
New coronavirus only ‘one small step from spilling over into humans' and sparking widespread outbreak, say scientists
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A NEW coronavirus may only be "a small step away from spilling over into humans", scientists have warned - sparking fears of another pandemic. Scientists believe the variant, called HKU5-CoV-2, may infect a broader range of animals than Covid-19 and may have more potential for jumping between species. 1 Dr Michael Letko, a molecular virologist at WSU's College of Veterinary Medicine, lead the research into the concerning variant Credit: Ted S. Warren/College of Veterinary Medicine/WSU American scientists fear the virus - found in China - may be one small mutation away from also being able to infect humans, which could lead to a widespread outbreak. The new study, published in Nature Communications, looked at a lesser-known group of coronaviruses called merbecoviruses. It includes HKU5 and MERS-CoV, which is responsible for the deadly Middle East Respiratory Syndrome. First noted in 2012, the virus typically spreads from infected camels to humans causes severe respiratory disease, which can be fatal to 34 per cent of its victims. The research team, which included scientists at Washington State University (WSU), the California Institute of Technology and the University of North Carolina, sought to understand how merbecoviruses infiltrate the cells of their hosts. While most bugs in the group seemed to pose little threat to people, scientists said one subgroup, HKU5, has concerning traits. Michael Letko, a virologist at WSU's College of Veterinary Medicine, said: "Merbecoviruses – and HKU5 viruses in particular – really hadn't been looked at much, but our study shows how these viruses infect cells. "What we also found is HKU5 viruses may be only a small step away from being able to spill over into humans." Like other coronaviruses, merbecoviruses rely on a spike protein to bind to receptors and invade host cells. Dr Letko's team used virus-like particles containing the part of the spike protein responsible for binding to receptors and tested their ability to infect cells in their lab. World is not prepared for looming Disease X pandemic says Doctor Tedros Ghebreyesus While most merbecoviruses appeared unlikely to be able to infect humans, HKU5 viruses — which have been found across Asia, Europe, Africa and the Middle East — were shown to use a host receptor known as ACE2, the same used by the SARS-CoV-2 virus that causes Covid-19. But for now HKU5 viruses can only use the ACE2 gene in bats and can't deploy it on humans nearly as well. Examining HKU5 viruses found in Asia - where their host is the Japanese house bat - the researchers demonstrated some mutations in the spike protein that may allow the viruses to bind to ACE2 receptors in other species, including humans. 'These viruses are so closely related to MERS, so we have to be concerned if they ever infect humans,' Dr Letko said. 'While there's no evidence they've crossed into people yet, the potential is there — and that makes them worth watching.' Dr Letko said the study and its methods could be used for future research projects and to help the development of new vaccines and treatments. What is the new Covid variant confirmed in the UK? The new strain - called NB.1.8.1 - has been spotted in the parts of the UK, such as Ireland and Wales. It's also cropped up in Europe, the US and Australia, as well as Egypt, the Maldives, Thailand, China and Hong Kong. The World Health Organisation (WHO) recently issued a warning over NB.1.8.1, designating it as a "variant under monitoring" due to its global spread and key mutations. 'Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation,' the WHO said. But while it may not be particularly severe, it may infect people more easily than previous variants, with some evidence suggesting that the variant binds more tightly to human cells. A recent study that has not yet been peer reviewed suggests that a person infected with NB.1.8.1 may be more likely to pass the virus on to someone else, compared to earlier variants. The WHO stressed that, based on available evidence, the variant's risk to public health was "low at the global level". "Currently approved Covid-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease," it added. Symptoms include sore throat, fatigue, fever, mild cough, muscle aches and a blocked nose. Some people may also get gastrointestinal symptoms. It's not the first time concerns have been raised over HKU5. Earlier this year, Chinese scientists warned that HKU5-CoV-2 may be able to jump straight from bats to humans without another animal in between. This suggests a higher potential for zoonotic spillover - when a disease spreads from animal to human. If there is no 'intermediate 'middle animal', it becomes harder to predict and prevent spillover events through interactions such as wildlife trading or hunting. "There is the potential for this new virus to spillover to human, like previous coronaviruses including SARS-CoV-2," said Dr Gary R McLean, a research fellow at the Imperial College London, who was not involved in the study. But he noted that, so far, there is no "evidence" that HKU5-CoV-2 can infect people – the paper is based on tests in a laboratory, showing the bug's "potential". "Hopefully the Chinese authorities now have good surveillance systems in place and the laboratories work to rigid safety standards that minimise the risk of spillover occurring," he said. The WHO has previously listed MERS and Covid as two of several diseases - alongside the mysterious disease X - that could spark a pandemic, but for which there is no specific treatment or vaccine.
Daily Mirror
19 hours ago
- Daily Mirror
All we know about Covid variant LP.8.1.1 spreading across England
Around 30 per cent of Covid cases in May were linked to the LP.8.1.1 variant Almost a third of Covid cases in England are linked to a specific variant, with people aged 80 and over most affected. The most recent data from the UK Health Security Agency (UKHSA), shows that around 30 per cent of coronavirus cases are caused by the LP.8.1.1 strain. Figures from between April 28 and May 11 revealed that 29.91 per cent of COVID-19 cases were classified as LP.8.1.1. This variant is a sublineage of LP.8.1, which is descended from Omicron. LP.8.1 was first detected in July 2024. It was designated as a 'variant under monitoring' by the World Health Organisation (WHO) in January. In the most recent report, LP.8.1 was also identified in England, accounting for 16.82 per cent of cases. Other variants linked to recent cases of Covid as documented by the UKHSA include JN.1 (14 per cent), XFG (12.5 per cent), XEC (11 per cent), MC.21.1 (5.6 per cent), KP.3.1.1 (2.8 per cent), and XDV (2.8 per cent). The UKHSA added that the highly transmissible NB.1.8.1 was detected in England at the same time, but has a 'low prevalence'. It said: 'There are currently 13 sequences of NB.1.8.1 in England, currently represented by its parent lineage XDV in Figure 4 due to low prevalence.' The update showed that between May 26 and June 1, referred to as week 22, cases of Covid slightly increased in England. People aged 80 and over were most affected by this rise. 'In week 22, 3,833 respiratory specimens reported through the Respiratory DataMart System were tested for SARS-CoV-2,' the UKHSA said. 'There were 219 positive samples for SARS-CoV-2. SARS-CoV-2 positivity increased slightly to 5.7 per cent compared with five per cent in the previous week, with the highest positivity in those aged 80 years and over at 7.4 per cent.' Hospital admissions due to Covid also rose that week. The overall weekly hospital admission rate for COVID-19 slightly increased to 1.49 (compared with 1.40 per 100,000 in the previous week). Hospital admission rates for COVID-19 were highest in the London region (increasing to 2.98 per 100,000 compared with 1.91 in the previous week). The highest hospital admission rate for COVID-19 was in those aged 85 years and over (slightly decreasing to 11.46 per 100,000 compared with 12.07 in the previous week). But the overall intensive care unit or high dependency unit rate for COVID-19 remained low at 0.04 per 100,000 (compared with 0.02 per 100,000 in the previous week). Symptoms It is not known if LP.8.1.1 causes any particular symptoms. Thomas Jeffries, a senior lecturer in microbiology at Western Sydney University, noted that its parent LP.8.1 has not seemed to lead to particularly severe symptoms. Writing for The Conversation, he said: 'Notably, the symptoms of LP.8.1 don't appear to be any more severe than other circulating strains. And the WHO has evaluated the additional public health risk LP.8.1 poses at a global level to be low. 'What's more, LP.8.1 remains a variant under monitoring, rather than a variant of interest or a variant of concern. In other words, these changes to the virus with LP.8.1 are small, and not likely to make a big difference to the trajectory of the pandemic.' The NHS lists Covid symptoms as: A high temperature or shivering (chills) – a high temperature means you feel hot to touch on your chest or back (you do not need to measure your temperature) A new, continuous cough – this means coughing a lot for more than an hour, or 3 or more coughing episodes in 24 hours A loss or change to your sense of smell or taste Shortness of breath Feeling tired or exhausted An aching body A headache A sore throat A blocked or runny nose Loss of appetite Diarrhoea Feeling sick or being sick. If you experience symptoms, the NHS advises staying home until you feel better. If you test positive for Covid, the NHS recommends staying home and avoiding contact with others for five days.
